Treatment approaches of gastrointestinal dysfunction in Parkinson's disease, therapeutical options and future perspectives

被引：15
|
作者：
Woitalla, D. [1 ]
Goetze, O. [2 ]
机构：
[1] Ruhr Univ Bochum, Dept Neurol, St Josef Hosp, D-44791 Bochum, Germany
[2] Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2011年 / 310卷 / 1-2期
关键词：
Gastrointestinal dysfunction; Treatment options; Enteric nervous system; Gastroparesis; Parkinson's disease; ENTERIC NERVOUS-SYSTEM; PLACEBO-CONTROLLED TRIAL; FUNCTIONAL DYSPEPSIA; LEWY BODIES; RESPONSE FLUCTUATIONS; CHRONIC CONSTIPATION; HEALTHY-VOLUNTEERS; NONMOTOR SYMPTOMS; GASTRIC-MOTILITY; 5-HT4; AGONIST;
D O I：
10.1016/j.jns.2011.06.050
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Gastrointestinal (GI) dysfunction is a common but underestimated feature in Parkinson's disease (PD). Out of the multimodal spectrum of treatment options, there currently are only a few pharmacological treatments available to improve gastrointestinal motility and symptoms. Because enteric nervous function is mainly regulated by transmitters different from those involved in the brain, dopamine replacement is not a treatment option in PD patients. This article focuses on the known regulative mechanism of Cl function and presents known and upcoming treatment options for GI dysfunction in PD. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码：152 / 158
页数：7
相关论文
共 50 条
  • [41] Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions
    Sun, Chichun
    Armstrong, Melissa J.
    BEHAVIORAL SCIENCES, 2021, 11 (04)
  • [42] Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
    Peter Jenner
    Translational Neurodegeneration, 4
  • [43] Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives
    Yadav, Virendra Kumar
    Dhanasekaran, Seshathiri
    Choudhary, Nisha
    Nathiya, Deepak
    Thakur, Vishal
    Gupta, Rachna
    Pramanik, Sheersha
    Kumar, Pankaj
    Gupta, Nishant
    Patel, Ashish
    FRONTIERS IN MEDICINE, 2025, 12
  • [44] Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future
    Jenner, Peter
    TRANSLATIONAL NEURODEGENERATION, 2015, 4
  • [45] COVID-19-Current Therapeutical Approaches and Future Perspectives
    Lupascu , Raluca Elisabeta
    Ilie, Marina Ionela
    Velescu, Bruno Stefan
    Udeanu, Denisa Ioana
    Sultana, Camelia
    Ruta, Simona
    Arsene, Andreea Letita
    PROCESSES, 2022, 10 (06)
  • [46] Gastrointestinal lymphomas: Perspectives and future therapeutic options
    Fischbach, W
    Dragosics, B
    CHIRURGISCHE GASTROENTEROLOGIE, 2002, 18 (01): : 67 - 69
  • [47] Management of Lower Urinary Tract Dysfunction in Parkinson's Disease: A Review of Recent Treatment Options
    Lurvey R.
    Duffy A.
    Rothschild J.
    Current Bladder Dysfunction Reports, 2014, 9 (3) : 214 - 220
  • [48] Intestinal microbiota and gastrointestinal dysfunction of patients with Parkinson's disease
    Baryshnikova, N. V.
    Ermolenko, E. I.
    Miliukhina, I.
    Kotyleva, M.
    Ivanova, A.
    Suvorov, A. N.
    HELICOBACTER, 2017, 22
  • [49] Gastrointestinal dysfunction in Parkinson's disease patients with morning akinesia
    Isaacson, S.
    Ondo, W.
    Pagan, F.
    MOVEMENT DISORDERS, 2014, 29 : S245 - S245
  • [50] Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics
    Han, Myat Noe
    Finkelstein, David I.
    McQuade, Rachel M.
    Diwakarla, Shanti
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
12345